As of September 2023 Tandem Diabetes Care has a market cap of $1.25 Billion. This makes Tandem Diabetes Care the world's 4586th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2023 | $1.25 B | -56.48% |
2022 | $2.89 B | -69.78% |
2021 | $9.56 B | 60.7% |
2020 | $5.95 B | 68.07% |
2019 | $3.54 B | 62.02% |
2018 | $2.18 B | 9051.27% |
2017 | $23.88 M | -63.75% |
2016 | $65.88 M | -81.56% |
2015 | $0.35 B | 18.94% |
2014 | $0.30 B | -49.15% |
2013 | $0.59 B |
On Sep 25th, 2023 the market cap of Tandem Diabetes Care was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $385.90 B | 30,577.45% | ๐บ๐ธ USA |
![]() Medtronic MDT | $106.40 B | 8,358.39% | ๐ฎ๐ช Ireland |
![]() ICU Medical
ICUI | $2.80 B | 122.68% | ๐บ๐ธ USA |
![]() DexCom DXCM | $8.36 B | 564.97% | ๐บ๐ธ USA |
![]() Insulet PODD | $10.79 B | 758.48% | ๐บ๐ธ USA |